XML 22 R6.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statement of Shareholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment [Member]
[1]
Common Stock [Member]
Preferred Stock [Member]
Capital Surplus [Member]
Retained Earnings [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
[1]
Treasury Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Total U.S. Bancorp Shareholders' Equity [Member]
Total U.S. Bancorp Shareholders' Equity [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
[1]
Noncontrolling Interests [Member]
Beginning Balance at Dec. 31, 2019 $ 52,483 $ (1,099) $ 21 $ 5,984 $ 8,475 $ 63,186 $ (1,099) $ (24,440) $ (1,373) $ 51,853 $ (1,099) $ 630
Shares, Beginning Balance at Dec. 31, 2019     1,534                  
Net income (loss) 4,985         4,959       4,959   26
Other comprehensive income (loss) 1,695               1,695 1,695    
Preferred stock dividends [2] (304)         (304)       (304)    
Common stock dividends (2,541)         (2,541)       (2,541)    
Issuance of preferred stock 486     486           486    
Call and redemption of preferred stock (500)     (487)   (13)       (500)    
Issuance of common and treasury stock 17       (154)     171   17    
Issuance of common and treasury stock, shares     4                  
Purchase of treasury stock $ (1,661)             (1,661)   (1,661)    
Purchase of treasury stock, shares (31)   (31)                  
Distributions to noncontrolling interests $ (25)                     (25)
Net other changes in noncontrolling interests (1)                     (1)
Stock option and restricted stock grants 190       190         190    
Shares, Ending Balance at Dec. 31, 2020     1,507                  
Ending Balance at Dec. 31, 2020 53,725   $ 21 5,983 8,511 64,188   (25,930) 322 53,095   630
Net income (loss) 7,985         7,963       7,963   22
Other comprehensive income (loss) (2,265)               (2,265) (2,265)    
Preferred stock dividends [3] (303)         (303)       (303)    
Common stock dividends (2,630)         (2,630)       (2,630)    
Issuance of preferred stock 2,221     2,221           2,221    
Call and redemption of preferred stock (1,850)     (1,833)   (17)       (1,850)    
Issuance of common and treasury stock 46       (169)     215   46    
Issuance of common and treasury stock, shares     5                  
Purchase of treasury stock $ (1,556)             (1,556)   (1,556)    
Purchase of treasury stock, shares (28)   (28)                  
Distributions to noncontrolling interests $ (20)                     (20)
Purchase of noncontrolling interests (167)                     (167)
Net other changes in noncontrolling interests 4                     4
Stock option and restricted stock grants $ 197       197         197    
Shares, Ending Balance at Dec. 31, 2021 1,500   1,484                  
Ending Balance at Dec. 31, 2021 $ 55,387   $ 21 6,371 8,539 69,201   (27,271) (1,943) 54,918   469
Net income (loss) 5,838         5,825       5,825   13
Other comprehensive income (loss) (9,464)               (9,464) (9,464)    
Preferred stock dividends [4] (296)         (296)       (296)    
Common stock dividends (2,829)         (2,829)       (2,829)    
Issuance of preferred stock 437     437           437    
Issuance of common and treasury stock 2,039       (32)     2,071   2,039    
Issuance of common and treasury stock, shares     48                  
Purchase of treasury stock $ (69)             (69)   (69)    
Purchase of treasury stock, shares (1)   (1)                  
Distributions to noncontrolling interests $ (13)                     (13)
Net other changes in noncontrolling interests (3)                     (3)
Stock option and restricted stock grants $ 205       205         205    
Shares, Ending Balance at Dec. 31, 2022 1,500   1,531                  
Ending Balance at Dec. 31, 2022 $ 51,232   $ 21 $ 6,808 $ 8,712 $ 71,901   $ (25,269) $ (11,407) $ 50,766   $ 466
[1] Effective January 1, 2020, the Company adopted accounting guidance which changed impairment recognition of financial instruments to a model that is based on expected losses rather than incurred losses. Upon adoption, the Company increased its allowance for credit losses and reduced retained earnings net of deferred taxes through a cumulative-effect adjustment.
[2] Reflects dividends declared per share on the Company’s Series A, Series B, Series F, Series H, Series I, Series J, Series K and Series L Non-Cumulative Perpetual Preferred Stock of $3,558.332, $889.58, $1,625.00, $1,287.52, $1,281.25, $1,325.00, $1,375.00 and $203.13, respectively.
[3] Reflects dividends declared per share on the Company’s Series A, Series B, Series F, Series I, Series J, Series K, Series L, Series M and Series N Non-Cumulative Perpetual Preferred Stock of $3,548.61, $887.153, $1,625.00, $232.953, $1,325.00, $1,375.00, $937.50, $952.778 and $202.986, respectively.
[4] Reflects dividends declared per share on the Company’s Series A, Series B, Series J, Series K, Series L, Series M, Series N and Series O Non-Cumulative Perpetual Preferred Stock of $3,965.458, $962.487, $1,325.00, $1,375.00, $937.50, $1,000.00, $925.00, and $1,050.00, respectively.